Kintor Pharmaceutical Ltd

Common Name
Kintor Pharmaceutical
Country
China (Mainland)
Sector
Healthcare
Industry
Biotechnology
Employees
168
Ticker
9939
Exchange
HONG KONG EXCHANGES AND CLEARING LTD
Description
Kintor Pharmaceutical Limited is an innovative biopharmaceutical company dedicated to the research, development, and commercialization of novel therapies. Specializing in the fields of oncology and de...

Kintor Pharmaceutical Waste Data Preview

In 2023, Kintor Pharmaceutical conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards. The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.

Metric (tonnes)2024202320222021 - 2017
Total Waste Generated
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Waste Recovered
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Hazardous Waste Generated
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Non-Hazardous Waste Disposed
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000

This table provides a simplified preview of selected waste data points. To access the complete dataset with full disclosures and structure, create a free account to purchase the full dataset.

Insights into Kintor Pharmaceutical's Waste Treatment Practices

In 2023, Kintor Pharmaceutical generated a total of 47 metric tonnes of waste.

Of this amount, 1.76% of Kintor Pharmaceutical's total waste generated was recovered through methods such as recycling, reuse, or composting, while 98.24% was disposed of through landfilling, incineration, or combustion.

Kintor Pharmaceutical's Waste Recovery Rate

2%

How much of Kintor Pharmaceutical's waste is recycled or recovered?

In 2023, Kintor Pharmaceutical reported a total waste generation of 47 metric tonnes, of which 1.76% was recovered through recycling, reuse, or composting. This low recovery rate highlights limited waste diversion and suggests that Kintor Pharmaceutical may be relying more heavily on landfill or incineration, underscoring opportunities for stronger resource recovery initiatives.

Has Kintor Pharmaceutical reduced its environmental waste footprint over time?

Since 2023, Kintor Pharmaceutical's total waste generation has increased by 1.17%, which may reflect expanding operations, weaker material efficiency, or insufficient waste reduction efforts.

Over the same period, Kintor Pharmaceutical's waste recovery rate decreased by 90.88%.

Kintor Pharmaceutical’s Waste Recovery vs. Disposal Over Time

20222023015304560tonnes
  • Total Waste Disposed
  • Total Waste Recovered

Insights into Kintor Pharmaceutical’s Generation of Hazardous and Non-Hazardous Waste

In 2023, Kintor Pharmaceutical generated a total of 47 metric tonnes of waste.

Of this amount, 98.24% of Kintor Pharmaceutical's total waste generated of was classified as hazardous waste, characterized by properties such as toxicity, flammability, corrosiveness, or reactivity that may pose risks to human health, ecosystems, or the environment. 1.76% was identified as non-hazardous waste, generally considered less harmful and subject to lighter regulatory controls.

Kintor Pharmaceutical’s Hazardous vs Non-Hazardous Waste Over Time

20222023015304560tonnes
  • Total Non-Hazardous Waste Generated
  • Total Hazardous Waste Generated

How Kintor Pharmaceutical reduced the environmental impact of its waste?

Since 2023, Kintor Pharmaceutical's total waste generation has increased by 1.17%, which may reflect expanding operations, weaker material efficiency, or insufficient waste reduction efforts.

Since 2023, Kintor Pharmaceutical's hazardous waste generation has increased by 21.66%, indicating a potential rise in the use of harmful materials, process inefficiencies, or limited hazardous waste reduction strategies..

Overall, Kintor Pharmaceutical has seen a recent increase in both total waste and hazardous waste, which may indicate growing operational pressures or insufficient controls on harmful materials.

Want Full Access to Kintor Pharmaceutical's Waste Management Dataset?
Sign Up